Pharmaceutical Executive
August 01, 2011
Issue PDF
0
0
Carrying the Weight of the Future
August 01, 2011
Columns
0
0
When it comes to the emerging markets, executing a few key elements of success are more important than ever.
August 01, 2011
Features
0
0
Why does the match against medicines compliance always seem to end in an easy knockout?
August 01, 2011
Features
0
0
A Q&A with Kristin Peck, the drugmaker's Executive Vice President, Worldwide Business Development and Innovation.
August 01, 2011
Columns
0
0
No one doubts the importance of health expenditures ? but then, euros, like dollars, don't grow on trees
August 01, 2011
Columns
0
0
Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed
August 01, 2011
Columns
0
0
It's a work in progres among EHR providers to offer a clear bridge between pharma and physicians.
August 01, 2011
From the Editor
0
0
What Big Pharma fails to see is how engagement in health policy is the biggest of reputation builders
August 01, 2011
Columns
0
0
A number of important decisions from the Supreme Court will affect drug marketing, research, and regulation
August 01, 2011
Columns
0
0
When faced with legislative scrutiny, be prepared, be truthful, and don't be afraid to say 'I don't know'...
August 01, 2011
0
0
Having progressively improved its financial standings over the past decade, this Eastern European market is now a bastion of potential-to the tune of $1.2 billion
August 01, 2011
Features
0
0
A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health
August 01, 2011
Columns
0
0
HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.
August 01, 2011
Columns
0
0
In medicines, as in life, the journey is just as important as the end result
August 01, 2011
Columns
0
0
Is Google+ the social media platform that pharma has been waiting for?